A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Clinical trial NCT06680830 · RECRUITING

Trial details

NCT number: NCT06680830
Sponsor: Neuron23 Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease Parkinson Idiopathic Parkinson Disease Early Parkinson Disease (Early PD)Parkinson Disease, Idiopathic

Start date: 2025-01-17
Primary completion: 2027-12-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.